Delivery Order SPE2DB24D1205-SPE2DB25FCXCN

Award Date 5/27/25
Potential Completion Date 5/28/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FEMRING 0.10 MG/DAY vaginal rings, with a ceiling value of $2,167.23 and a completion date of April 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,668.51 contract is for the delivery of FEMRING 0.05 MG/DAY vaginal rings, with a period of performance through April 16, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of FEMRING 0.05 MG/DAY vaginal rings, with a potential value of $2,884.82 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide FEMRING 0.10 MG/DAY Vaginal Rings. The contract has a ceiling value of $1,768.00 and a performance period through March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of FEMRING 0.10 MG/DAY vaginal rings, with a ceiling value of $3,186.66 and a performance period through March 28, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,597.89, is for the supply of FEMRING 0.10 MG/DAY vaginal rings. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a $1,193.47 fixed-price delivery order awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of FEMRING 0.05 MG/DAY vaginal rings to the U.S. government. The award was made by the Medical Supply Chain, a defense agency under the Defense Logistics Agency (DLA) Troop Support. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $7,921.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FEMRING 0.05 MG/DAY vaginal rings, a medical product used for various healthcare applications. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $13,887.31 contract is for the delivery of FEMRING 0.10 MG/DAY vaginal rings to support military treatment programs and facilities. This order falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,558.51, is a delivery order for the supply of FEMRING 0.05 MG/DAY vaginal rings. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCXCN
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FEMRING 0.10 MG/DAY VAG RINGS. The contract has a firm fixed price, a ceiling value of $19,330.23, and a period of performance through May 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/31/25, 1:02 AM